Perspective Therapeutics and PharmaLogic announce collaboration for the development and production of theranostics for cancer care

BOCA RATON, Fla. and RICHLAND, Wash., March 14, 2023 /PRNewswire/ — PharmaLogic Holdings Corp. (“PharmaLogic” or “the Company”), a contract development and manufacturing organization and radiopharmaceutical manufacturer, today announces the signature of a Master Services Agreement with…

Click here to view original post